Despite their potential, several challenges must be addressed:
Biocompatibility and toxicity: Ensuring that nanocarriers are non-toxic and do not elicit an immune response is crucial. Manufacturing and scalability: Producing nanocarriers at a large scale while maintaining consistency and quality is challenging. Regulatory hurdles: Gaining regulatory approval for new nanocarrier-based therapies can be a lengthy and complex process. Stability: Ensuring that nanocarriers remain stable under physiological conditions is essential for their effectiveness.
